Gottlieb says new data prompted FDA to delay decision on vaccine for young kids

Dr. Scott Gottlieb on when the FDA will authorize a Covid vaccine for kidsПодробнее

News Wrap: FDA delays approval of Pfizer's COVID-19 vaccine for children under 5Подробнее

How the FDA's delay on COVID vaccines for young children affects familiesПодробнее

Dr. Scott Gottlieb on the timeline for children's Covid vaccineПодробнее

Dr. Scott Gottlieb breaks down Pfizer's delayed Covid vaccine for young childrenПодробнее

Gottlieb said "it's certainly reasonable" to start seeing children ages 5-11 be fully vaccinated ���Подробнее

Gottlieb doesn't expect COVID-19 vaccine for kids under 5 before late MarchПодробнее

Dr. Scott Gottlieb: Covid vaccines likely won't be required at most schoolsПодробнее

FDA delays meeting on COVID vaccines for kids under 5Подробнее

Gottlieb: FDA's new guidelines are in line with expectationsПодробнее

Dr. Scott Gottlieb: People need to be prudent, even if they're vaccinatedПодробнее

Families disappointed with Pfizer's delay in vaccines for children under 5Подробнее

Pfizer Delays FDA Request For COVID Vaccine For Children Under 5Подробнее

Gottlieb says infections among young people are fueling new COVID-19 hotspotsПодробнее

Review of COVID-19 Pfizer vaccine for children under 5 delayedПодробнее

Dr. Scott Gottlieb: Merck could seek emergency FDA nod for Covid pill this weekПодробнее

Expect delays in clinical trials unrelated to Covid-19, says former FDA chief Scott GottliebПодробнее

Former FDA chief Dr. Scott Gottlieb on post-vaccine heart inflammation symptomsПодробнее

Dr. Scott Gottlieb says he thinks virus will always circulate at a low-levelПодробнее